亚太地区心力衰竭患者心房颤动的种族差异
在新加坡和新西兰前瞻性纳入1746例确诊心衰患者,比较不同种族间心房颤动(AF)的患病率及临床相关因素。结果显示新加坡亚裔AF患病率显著低于新西兰欧裔(24% vs 63%,p<0.001),且AF与2年死亡和心衰住院复合终点风险升高相关(HR 1.19,95%CI 1.02-1.38)。
要点
- 新加坡亚裔心衰患者AF患病率显著低于新西兰欧裔(24% vs 63%)。
- 亚裔合并糖尿病者AF风险更低(OR 0.66,95%CI 0.50-0.88),欧裔无此关联。
- AF与2年死亡和心衰住院复合终点风险升高相关(HR 1.19,95%CI 1.02-1.38)。
核心结论
- 亚太地区亚裔心衰患者AF患病率显著低于新西兰欧裔,即使调整年龄、临床和超声心动图协变量后仍存在差异。
- AF与2年死亡和心衰住院复合终点风险升高相关(HR 1.19,95%CI 1.02-1.38)。
研究设计与样本
- 前瞻性研究,在新加坡和新西兰纳入1746例确诊心衰患者。
- 人群特征:62%亚裔,26%女性,平均年龄66岁(SD 13),平均射血分数37%(SD 16%)。
主要发现
- 总体AF患病率为39%。
- 新加坡亚裔AF患病率为24%,新西兰欧裔为63%(p<0.001),无论EF分组如何交互作用均不显著(pinteraction for EF=0.39)。
- AF患者更老、BMI更高,更常有高血压、卒中、外周血管病、肾脏病、慢性呼吸系统疾病和饮酒史,但糖尿病较少。
- 亚裔糖尿病患者合并心衰时AF风险低于非糖尿病亚裔(OR 0.66,95%CI 0.50-0.88),而欧裔中糖尿病与AF无显著关联(OR 1.22,95%CI 0.85-1.75)(pinteraction for ethnicity=0.01)。
临床怎么用
- 在亚太地区心衰患者中评估AF风险时应考虑种族差异,亚裔患者AF患病率可能较低。
- 亚裔心衰合并糖尿病患者需关注其AF风险可能进一步降低的关联。
- 心衰患者合并AF时需注意2年死亡和心衰住院复合终点风险升高。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Ethnic differences in the prevalence of atrial fibrillation (AF) in heart failure (HF) remain unclear. We compared the prevalence and clinical correlates of AF among different ethnicities in an Asian-Pacific population with HF. METHODS: Patients with validated HF were prospectively studied across Singapore and New Zealand (NZ). RESULTS: Among 1746 patients with HF (62% Asian, 26% women, mean age 66 (SD 13) years, mean ejection fraction (EF) 37 (SD 16%), 39% had AF. The prevalence of AF was markedly lower in Singapore-Asians than NZ-Europeans (24% vs 63%; p<0.001), even after adjusting for age, clinical and echocardiographic covariates, regardless of EF group (pinteraction for EF=0.39). Patients with AF were older, had higher body mass index and were more likely to have a history of hypertension, stroke, peripheral vascular disease, renal disease, chronic respiratory disease and increased alcohol intake, but less likely to have diabetes. Clinical correlates were similar for Asians and NZ-Europeans, except diabetes: Asian diabetic patients with HF had less AF compared with Asian patients without diabetes (OR 0.66, 95% CI 0.50 to 0.88), whereas among NZ-Europeans there was no significant association between diabetes and AF (OR 1.22, 95% CI 0.85 to 1.75) (pinteraction for ethnicity=0.01). AF was associated with a higher crude composite outcome of mortality and HF hospitalisations at 2 years (HR 1.19, 95% CI 1.02 to 1.38). CONCLUSION: There is a strikingly lower prevalence of AF among Asian compared with NZ-European patients with HF. The underlying mechanisms for the lower prevalence of AF among Asians, particularly in the presence of diabetes, deserve further study. TRIAL REGISTRATION NUMBER: ACTRN12610000374066.
引用
- Tan ESJ, Tay WT, Teng TK, et al. Ethnic differences in atrial fibrillation in patients with heart failure from Asia-Pacific. Heart. 2019. PMID: 30661038. doi:10.1136/heartjnl-2018-314077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。